Results 221 to 230 of about 168,749 (376)
Sex‐related pathophysiological mechanisms may be present before symptoms of HFpEF develop
Abstract Aims Understanding sex‐related cardiovascular differences in those with pre‐HFpEF (asymptomatic with normal ejection fraction, elevated natriuretic peptides and structural or functional heart disease) could help explain why females are more likely to develop symptomatic HFpEF compared with males.
B. Wong+6 more
wiley +1 more source
Predicting cerebral infarction and transient ischemic attack in healthy individuals and those with dysmetabolism: a machine learning approach combined with routine blood tests. [PDF]
Yang Y+7 more
europepmc +1 more source
Transient Ischemic Attack Due to Dissection of the Middle Cerebral Artery. Case Report.
Yasushi Iwamuro+5 more
openalex +2 more sources
Treatment of transient ischemic attacks. [PDF]
C H Millikan, F H McDowell
openaire +3 more sources
Abstract Aims Cardiogenic shock (CS) is the deadliest manifestation of acute heart failure, with persistently high mortality rates and a lack of recent therapeutic breakthroughs. Accurate risk prediction is crucial in clinical decision‐making and the design of future clinical trials.
Elina Hynninen+14 more
wiley +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana+6 more
wiley +1 more source
This study evaluated the safety and efficacy of a novel primary closure technique in carotid endarterectomy compared with traditional methods. Conducted over 8 years at three university hospitals, this study included 184 patients.
Amir Ahmad Arabzadeh, MD+3 more
doaj
Isolated cardiac sarcoidosis presenting as transient ischemic attack. [PDF]
Vasquez MA, Andrade-Bucknor S.
europepmc +1 more source
Headache at Stroke Onset in 2196 Patients With Ischemic Stroke or Transient Ischemic Attack [PDF]
Susanne Tentschert+4 more
openalex +1 more source
Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL.
Matteo Pagnesi+21 more
wiley +1 more source